Filing Details

Accession Number:
0001179110-11-014287
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-18 11:53:03
Reporting Period:
2011-10-17
Filing Date:
2011-10-18
Accepted Time:
2011-10-18 11:53:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236371 D Gregory Perry C/O Immunogen, Inc.
830 Winter Street
Waltham MA 02451
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-17 8,333 $4.32 8,333 No 4 M Direct
Common Stock Disposition 2011-10-17 8,333 $13.40 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-10-17 8,333 $4.32 8,333 $4.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
83,335 2010-01-09 2019-01-09 No 4 M Direct
Footnotes
  1. Exercisable as to 31,250 shares commencing on January 9, 2010, and as to 7,812.5 shares on each April 9th, July 9th, October 9th, and January 9th thereafter, beginning on April 9, 2010.
  2. Weighted average price of shares sold.
  3. The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on May 23, 2011.